Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 8/2013

01.12.2013 | Original Article

Pancreatoduodenectomy—current status of surgical and perioperative techniques in Germany

verfasst von: Christina Haane, Wolf Arif Mardin, Britta Schmitz, Sameer Dhayat, Richard Hummel, Norbert Senninger, Christina Schleicher, Soeren Torge Mees

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Pancreatoduodenectomy in Germany is performed by a broad range of hospitals. A diversity of operative techniques is employed as no guidelines exist for intra- and perioperative management. We carried out a national survey to determine the de facto German standards for pancreatoduodenectomy, assess quality assurance measures, and identify relevant issues for further investigation.

Methods

A questionnaire evaluating major outcome variables, case load, preferred surgical procedures, and perioperative management during pancreatoduodenectomy was developed and sent to 211 German hospitals performing >12 pancreatoduodenectomies per year (requirement for certification as a pancreas center). Statistical analysis was carried out using the Fisher Exact, Mann–Whitney U, and Spearman tests.

Results

The final response rate was 86 % (182/211). The preferred technique and de facto German standard for pancreatoduodenectomy was pylorus-preserving pancreatoduodenectomy with pancreatojejunostomy carried out via duct-to-mucosa anastomosis with interrupted sutures using PDS 4.0. The minority of German pancreas centers were certified (18–48 %). The certification rate increased with higher capacity levels and case load (P < 0.05); however, significant correlations between the fistula rate and hospital case load, hospital capacity level, or hospital certification status were not seen.

Conclusion

This study revealed a distinct variety of management strategies for pancreatic surgery and available evidence-based data was not necessarily translated into clinical practice. The limited certification rate represented a shortcoming of quality assurance. The data emphasize the need for further trials to answer the questions whether hospital certifications and omission of drains improve outcome after pancreatoduodenectomy and for the establishment of guidelines for pancreatoduodenectomy.
Literatur
1.
Zurück zum Zitat Glanemann M, Bahra M, Neuhaus P (2008) Pylorus-preserving pancreatic head resection: a new standard for tumors. Chirurg 79(12):1107–1114PubMedCrossRef Glanemann M, Bahra M, Neuhaus P (2008) Pylorus-preserving pancreatic head resection: a new standard for tumors. Chirurg 79(12):1107–1114PubMedCrossRef
2.
Zurück zum Zitat Smigielski J, Piskorz L, Kutwin L, Brocki M (2012) Comparison of early results of surgical treatment in patients with pancreatic cancer. Pol Przegl Chir 84(1):1–5PubMedCrossRef Smigielski J, Piskorz L, Kutwin L, Brocki M (2012) Comparison of early results of surgical treatment in patients with pancreatic cancer. Pol Przegl Chir 84(1):1–5PubMedCrossRef
3.
Zurück zum Zitat McKay A, Mackenzie S, Sutherland FR, Bathe OF, Doig C, Dort J, Vollmer CM Jr, Dixon E (2006) Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg 93(8):929–936PubMedCrossRef McKay A, Mackenzie S, Sutherland FR, Bathe OF, Doig C, Dort J, Vollmer CM Jr, Dixon E (2006) Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg 93(8):929–936PubMedCrossRef
4.
Zurück zum Zitat Wente MN, Shrikhande SV, Muller MW, Diener MK, Seiler CM, Friess H, Buchler MW (2007) Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg 193(2):171–183PubMedCrossRef Wente MN, Shrikhande SV, Muller MW, Diener MK, Seiler CM, Friess H, Buchler MW (2007) Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg 193(2):171–183PubMedCrossRef
5.
Zurück zum Zitat Schlitt HJ, Schmidt U, Simunec D, Jager M, Aselmann H, Neipp M, Piso P (2002) Morbidity and mortality associated with pancreatogastrostomy and pancreatojejunostomy following partial pancreatoduodenectomy. Br J Surg 89(10):1245–1251PubMedCrossRef Schlitt HJ, Schmidt U, Simunec D, Jager M, Aselmann H, Neipp M, Piso P (2002) Morbidity and mortality associated with pancreatogastrostomy and pancreatojejunostomy following partial pancreatoduodenectomy. Br J Surg 89(10):1245–1251PubMedCrossRef
6.
Zurück zum Zitat di Sebastiano P, Festa L, De Bonis A, Ciuffreda A, Valvano MR, Andriulli A, di Mola FF (2011) A modified fast-track program for pancreatic surgery: a prospective single-center experience. Langenbecks Arch Surg 396(3):345–351PubMedCrossRef di Sebastiano P, Festa L, De Bonis A, Ciuffreda A, Valvano MR, Andriulli A, di Mola FF (2011) A modified fast-track program for pancreatic surgery: a prospective single-center experience. Langenbecks Arch Surg 396(3):345–351PubMedCrossRef
7.
Zurück zum Zitat van Bree SH, Vlug MS, Bemelman WA, Hollmann MW, Ubbink DT, Zwinderman AH, de Jonge WJ, Snoek SA, Bolhuis K, van der Zanden E et al (2011) Faster recovery of gastrointestinal transit after laparoscopy and fast-track care in patients undergoing colonic surgery. Gastroenterology 141(3):872–880, e871-874PubMedCrossRef van Bree SH, Vlug MS, Bemelman WA, Hollmann MW, Ubbink DT, Zwinderman AH, de Jonge WJ, Snoek SA, Bolhuis K, van der Zanden E et al (2011) Faster recovery of gastrointestinal transit after laparoscopy and fast-track care in patients undergoing colonic surgery. Gastroenterology 141(3):872–880, e871-874PubMedCrossRef
8.
Zurück zum Zitat Hall TC, Dennison AR, Bilku DK, Metcalfe MS, Garcea G (2012) Enhanced recovery programmes in hepatobiliary and pancreatic surgery: a systematic review. Ann R Coll Surg Engl 94(5):318–326PubMedCrossRef Hall TC, Dennison AR, Bilku DK, Metcalfe MS, Garcea G (2012) Enhanced recovery programmes in hepatobiliary and pancreatic surgery: a systematic review. Ann R Coll Surg Engl 94(5):318–326PubMedCrossRef
9.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138(1):8–13PubMedCrossRef Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138(1):8–13PubMedCrossRef
10.
Zurück zum Zitat Shukla PJ, Barreto SG, Fingerhut A, Bassi C, Buchler MW, Dervenis C, Gouma D, Izbicki JR, Neoptolemos J, Padbury R et al (2010) Toward improving uniformity and standardization in the reporting of pancreatic anastomoses: a new classification system by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 147(1):144–153PubMedCrossRef Shukla PJ, Barreto SG, Fingerhut A, Bassi C, Buchler MW, Dervenis C, Gouma D, Izbicki JR, Neoptolemos J, Padbury R et al (2010) Toward improving uniformity and standardization in the reporting of pancreatic anastomoses: a new classification system by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 147(1):144–153PubMedCrossRef
11.
Zurück zum Zitat Balzano G, Zerbi A, Capretti G, Rocchetti S, Capitanio V, Di Carlo V (2008) Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy. Br J Surg 95(3):357–362PubMedCrossRef Balzano G, Zerbi A, Capretti G, Rocchetti S, Capitanio V, Di Carlo V (2008) Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy. Br J Surg 95(3):357–362PubMedCrossRef
12.
Zurück zum Zitat Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128–1137PubMedCrossRef Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128–1137PubMedCrossRef
13.
Zurück zum Zitat de Wilde RF, Besselink MG, van der Tweel I, de Hingh IH, van Eijck CH, Dejong CH, Porte RJ, Gouma DJ, Busch OR, Molenaar IQ (2012) Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br J Surg 99(3):404–410PubMedCrossRef de Wilde RF, Besselink MG, van der Tweel I, de Hingh IH, van Eijck CH, Dejong CH, Porte RJ, Gouma DJ, Busch OR, Molenaar IQ (2012) Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br J Surg 99(3):404–410PubMedCrossRef
14.
Zurück zum Zitat Topal B, Van de Sande S, Fieuws S, Penninckx F (2007) Effect of centralization of pancreaticoduodenectomy on nationwide hospital mortality and length of stay. Br J Surg 94(11):1377–1381PubMedCrossRef Topal B, Van de Sande S, Fieuws S, Penninckx F (2007) Effect of centralization of pancreaticoduodenectomy on nationwide hospital mortality and length of stay. Br J Surg 94(11):1377–1381PubMedCrossRef
15.
Zurück zum Zitat van Heek NT, Kuhlmann KF, Scholten RJ, de Castro SM, Busch OR, van Gulik TM, Obertop H, Gouma DJ (2005) Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 242(6):781–788, discussion 788–790PubMedCrossRef van Heek NT, Kuhlmann KF, Scholten RJ, de Castro SM, Busch OR, van Gulik TM, Obertop H, Gouma DJ (2005) Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 242(6):781–788, discussion 788–790PubMedCrossRef
16.
Zurück zum Zitat Post S (2010) Quality management—certification: curse or blessing? Zentralbl Chir 135(1):1–2PubMedCrossRef Post S (2010) Quality management—certification: curse or blessing? Zentralbl Chir 135(1):1–2PubMedCrossRef
17.
Zurück zum Zitat Adler TS G, Bischoff SC, Brambs H-J, Feuerbach S, Grabenbauer G, Hahn S, Heinemann V, Hohenberger W, Langrehr JM, Lutz MP, Micke O, Neuhaus H, Neuhaus P, Oettle H, Schlag PM, Schmid R, Schmiegel W, Schlottmann K, Werner J, Wiedenmann B, Kopp I (2007) S3-Leitlinie, Exokrines Pankreaskarzinom 2007. Z Gastroenterol 45(6):487–523CrossRef Adler TS G, Bischoff SC, Brambs H-J, Feuerbach S, Grabenbauer G, Hahn S, Heinemann V, Hohenberger W, Langrehr JM, Lutz MP, Micke O, Neuhaus H, Neuhaus P, Oettle H, Schlag PM, Schmid R, Schmiegel W, Schlottmann K, Werner J, Wiedenmann B, Kopp I (2007) S3-Leitlinie, Exokrines Pankreaskarzinom 2007. Z Gastroenterol 45(6):487–523CrossRef
18.
Zurück zum Zitat Shen HN, Lu CL (2011) Incidence, resource use, and outcome of acute pancreatitis with/without intensive care: a nationwide population-based study in Taiwan. Pancreas 40(1):10–15PubMedCrossRef Shen HN, Lu CL (2011) Incidence, resource use, and outcome of acute pancreatitis with/without intensive care: a nationwide population-based study in Taiwan. Pancreas 40(1):10–15PubMedCrossRef
19.
Zurück zum Zitat Sargent M, Boeck S, Heinemann V, Jauch KW, Seufferlein T, Bruns CJ (2011) Surgical treatment concepts for patients with pancreatic cancer in Germany—results from a national survey conducted among members of the "Chirurgische Arbeitsgemeinschaft Onkologie" (CAO) and the "Arbeitsgemeinschaft Internistische Onkologie" (AIO) of the Germany Cancer Society (DKG). Langenbecks Arch Surg 396(2):223–229PubMedCrossRef Sargent M, Boeck S, Heinemann V, Jauch KW, Seufferlein T, Bruns CJ (2011) Surgical treatment concepts for patients with pancreatic cancer in Germany—results from a national survey conducted among members of the "Chirurgische Arbeitsgemeinschaft Onkologie" (CAO) and the "Arbeitsgemeinschaft Internistische Onkologie" (AIO) of the Germany Cancer Society (DKG). Langenbecks Arch Surg 396(2):223–229PubMedCrossRef
20.
Zurück zum Zitat Alsfasser G, Kittner J, Eisold S, Klar E (2012) Volume-outcome relationship in pancreatic surgery: the situation in Germany. Surgery 152(3 Suppl 1):S50–S55PubMedCrossRef Alsfasser G, Kittner J, Eisold S, Klar E (2012) Volume-outcome relationship in pancreatic surgery: the situation in Germany. Surgery 152(3 Suppl 1):S50–S55PubMedCrossRef
21.
Zurück zum Zitat Karanicolas PJ, Davies E, Kunz R, Briel M, Koka HP, Payne DM, Smith SE, Hsu HP, Lin PW, Bloechle C et al (2007) The pylorus: take it or leave it? Systematic review and meta-analysis of pylorus-preserving versus standard Whipple pancreaticoduodenectomy for pancreatic or periampullary cancer. Ann Surg Oncol 14(6):1825–1834PubMedCrossRef Karanicolas PJ, Davies E, Kunz R, Briel M, Koka HP, Payne DM, Smith SE, Hsu HP, Lin PW, Bloechle C et al (2007) The pylorus: take it or leave it? Systematic review and meta-analysis of pylorus-preserving versus standard Whipple pancreaticoduodenectomy for pancreatic or periampullary cancer. Ann Surg Oncol 14(6):1825–1834PubMedCrossRef
22.
Zurück zum Zitat Diener MK, Heukaufer C, Schwarzer G, Seiler CM, Antes G, Buchler MW, Knaebel HP (2008) Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 2, CD006053PubMed Diener MK, Heukaufer C, Schwarzer G, Seiler CM, Antes G, Buchler MW, Knaebel HP (2008) Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 2, CD006053PubMed
23.
Zurück zum Zitat Diener MK, Fitzmaurice C, Schwarzer G, Seiler CM, Antes G, Knaebel HP, Buchler MW (2011) Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 5, CD006053PubMed Diener MK, Fitzmaurice C, Schwarzer G, Seiler CM, Antes G, Knaebel HP, Buchler MW (2011) Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 5, CD006053PubMed
24.
Zurück zum Zitat Oussoultzoglou E, Bachellier P, Bigourdan JM, Weber JC, Nakano H, Jaeck D (2004) Pancreaticogastrostomy decreased relaparotomy caused by pancreatic fistula after pancreaticoduodenectomy compared with pancreaticojejunostomy. Arch Surg 139(3):327–335PubMedCrossRef Oussoultzoglou E, Bachellier P, Bigourdan JM, Weber JC, Nakano H, Jaeck D (2004) Pancreaticogastrostomy decreased relaparotomy caused by pancreatic fistula after pancreaticoduodenectomy compared with pancreaticojejunostomy. Arch Surg 139(3):327–335PubMedCrossRef
25.
Zurück zum Zitat Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA, Lillemoe KD, Pitt HA (1995) A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222(4):580–588, discussion 588–592PubMed Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA, Lillemoe KD, Pitt HA (1995) A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222(4):580–588, discussion 588–592PubMed
26.
Zurück zum Zitat Wellner UF, Sick O, Olschewski M, Adam U, Hopt UT, Keck T (2012) Randomized controlled single-center trial comparing pancreatogastrostomy versus pancreaticojejunostomy after partial pancreatoduodenectomy. J Gastrointest Surg 16(9):1686–1695PubMedCrossRef Wellner UF, Sick O, Olschewski M, Adam U, Hopt UT, Keck T (2012) Randomized controlled single-center trial comparing pancreatogastrostomy versus pancreaticojejunostomy after partial pancreatoduodenectomy. J Gastrointest Surg 16(9):1686–1695PubMedCrossRef
27.
Zurück zum Zitat Wellner UF, Brett S, Bruckner T, Limprecht R, Rossion I, Seiler C, Sick O, Wegener I, Hopt UT, Keck T (2012) Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after partial PANCreatoduodenectomy (RECOPANC): study protocol of a randomized controlled trial UTN U1111-1117-9588. Trials 13:45PubMedCrossRef Wellner UF, Brett S, Bruckner T, Limprecht R, Rossion I, Seiler C, Sick O, Wegener I, Hopt UT, Keck T (2012) Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after partial PANCreatoduodenectomy (RECOPANC): study protocol of a randomized controlled trial UTN U1111-1117-9588. Trials 13:45PubMedCrossRef
28.
Zurück zum Zitat Greene BS, Loubeau JM, Peoples JB, Elliott DW (1991) Are pancreatoenteric anastomoses improved by duct-to-mucosa sutures? Am J Surg 161(1):45–49, discussion 49–50PubMedCrossRef Greene BS, Loubeau JM, Peoples JB, Elliott DW (1991) Are pancreatoenteric anastomoses improved by duct-to-mucosa sutures? Am J Surg 161(1):45–49, discussion 49–50PubMedCrossRef
29.
Zurück zum Zitat Matsumoto Y, Fujii H, Miura K, Inoue S, Sekikawa T, Aoyama H, Ohnishi N, Sakai K, Suda K (1992) Successful pancreatojejunal anastomosis for pancreatoduodenectomy. Surg Gynecol Obstet 175(6):555–562PubMed Matsumoto Y, Fujii H, Miura K, Inoue S, Sekikawa T, Aoyama H, Ohnishi N, Sakai K, Suda K (1992) Successful pancreatojejunal anastomosis for pancreatoduodenectomy. Surg Gynecol Obstet 175(6):555–562PubMed
30.
Zurück zum Zitat Berger AC, Howard TJ, Kennedy EP, Sauter PK, Bower-Cherry M, Dutkevitch S, Hyslop T, Schmidt CM, Rosato EL, Lavu H et al (2009) Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg 208(5):738–747, discussion 747–739PubMedCrossRef Berger AC, Howard TJ, Kennedy EP, Sauter PK, Bower-Cherry M, Dutkevitch S, Hyslop T, Schmidt CM, Rosato EL, Lavu H et al (2009) Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg 208(5):738–747, discussion 747–739PubMedCrossRef
31.
Zurück zum Zitat Kim JH, Yoo BM, Kim WH (2009) Which method should we select for pancreatic anastomosis after pancreaticoduodenectomy? World J Surg 33(2):326–332PubMedCrossRef Kim JH, Yoo BM, Kim WH (2009) Which method should we select for pancreatic anastomosis after pancreaticoduodenectomy? World J Surg 33(2):326–332PubMedCrossRef
32.
Zurück zum Zitat Pessaux P, Sauvanet A, Mariette C, Paye F, Muscari F, Cunha AS, Sastre B, Arnaud JP (2011) External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial. Ann Surg 253(5):879–885PubMedCrossRef Pessaux P, Sauvanet A, Mariette C, Paye F, Muscari F, Cunha AS, Sastre B, Arnaud JP (2011) External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial. Ann Surg 253(5):879–885PubMedCrossRef
33.
Zurück zum Zitat Zhou Y, Yang C, Wang S, Chen J, Li B (2011) Does external pancreatic duct stent decrease pancreatic fistula rate after pancreatic resection?: a meta-analysis. Pancreatology 11(3):362–370PubMedCrossRef Zhou Y, Yang C, Wang S, Chen J, Li B (2011) Does external pancreatic duct stent decrease pancreatic fistula rate after pancreatic resection?: a meta-analysis. Pancreatology 11(3):362–370PubMedCrossRef
34.
Zurück zum Zitat Frozanpor F, Lundell L, Segersvard R, Arnelo U (2012) The effect of prophylactic transpapillary pancreatic stent insertion on clinically significant leak rate following distal pancreatectomy: results of a prospective controlled clinical trial. Ann Surg 255(6):1032–1036PubMedCrossRef Frozanpor F, Lundell L, Segersvard R, Arnelo U (2012) The effect of prophylactic transpapillary pancreatic stent insertion on clinically significant leak rate following distal pancreatectomy: results of a prospective controlled clinical trial. Ann Surg 255(6):1032–1036PubMedCrossRef
35.
Zurück zum Zitat Xiong JJ, Altaf K, Mukherjee R, Huang W, Hu WM, Li A, Ke NW, Liu XB (2012) Systematic review and meta-analysis of outcomes after intraoperative pancreatic duct stent placement during pancreaticoduodenectomy. Br J Surg 99(8):1050–1061PubMedCrossRef Xiong JJ, Altaf K, Mukherjee R, Huang W, Hu WM, Li A, Ke NW, Liu XB (2012) Systematic review and meta-analysis of outcomes after intraoperative pancreatic duct stent placement during pancreaticoduodenectomy. Br J Surg 99(8):1050–1061PubMedCrossRef
36.
Zurück zum Zitat Gans SL, van Westreenen HL, Kiewiet JJ, Rauws EA, Gouma DJ, Boermeester MA (2012) Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula. Br J Surg 99(6):754–760PubMedCrossRef Gans SL, van Westreenen HL, Kiewiet JJ, Rauws EA, Gouma DJ, Boermeester MA (2012) Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula. Br J Surg 99(6):754–760PubMedCrossRef
37.
Zurück zum Zitat Kollmar O, Moussavian MR, Richter S, de Roi P, Maurer CA, Schilling MK (2008) Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial. Eur J Surg Oncol 34(8):868–875PubMedCrossRef Kollmar O, Moussavian MR, Richter S, de Roi P, Maurer CA, Schilling MK (2008) Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial. Eur J Surg Oncol 34(8):868–875PubMedCrossRef
38.
Zurück zum Zitat Alghamdi AA, Jawas AM, Hart RS (2007) Use of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis. Can J Surg 50(6):459–466PubMed Alghamdi AA, Jawas AM, Hart RS (2007) Use of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis. Can J Surg 50(6):459–466PubMed
39.
Zurück zum Zitat Graham JA, Johnson LB, Haddad N, Al-Kawas F, Carroll J, Jha R, Wong J, Maglaris D, Mertens S, Fishbein T (2011) A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy. Am J Surg 201(4):481–485PubMedCrossRef Graham JA, Johnson LB, Haddad N, Al-Kawas F, Carroll J, Jha R, Wong J, Maglaris D, Mertens S, Fishbein T (2011) A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy. Am J Surg 201(4):481–485PubMedCrossRef
40.
Zurück zum Zitat Vanounou T, Pratt WB, Callery MP, Vollmer CM Jr (2007) Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands. J Am Coll Surg 205(4):546–557PubMedCrossRef Vanounou T, Pratt WB, Callery MP, Vollmer CM Jr (2007) Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands. J Am Coll Surg 205(4):546–557PubMedCrossRef
41.
Zurück zum Zitat Tsuji M, Kimura H, Konishi K, Yabushita K, Maeda K, Kuroda Y (1998) Management of continuous anastomosis of pancreatic duct and jejunal mucosa after pancreaticoduodenectomy: historical study of 300 patients. Surgery 123(6):617–621PubMedCrossRef Tsuji M, Kimura H, Konishi K, Yabushita K, Maeda K, Kuroda Y (1998) Management of continuous anastomosis of pancreatic duct and jejunal mucosa after pancreaticoduodenectomy: historical study of 300 patients. Surgery 123(6):617–621PubMedCrossRef
42.
Zurück zum Zitat Bassi C, Molinari E, Malleo G, Crippa S, Butturini G, Salvia R, Talamini G, Pederzoli P (2010) Early versus late drain removal after standard pancreatic resections: results of a prospective randomized trial. Ann Surg 252(2):207–214PubMedCrossRef Bassi C, Molinari E, Malleo G, Crippa S, Butturini G, Salvia R, Talamini G, Pederzoli P (2010) Early versus late drain removal after standard pancreatic resections: results of a prospective randomized trial. Ann Surg 252(2):207–214PubMedCrossRef
43.
Zurück zum Zitat Kawai M, Tani M, Terasawa H, Ina S, Hirono S, Nishioka R, Miyazawa M, Uchiyama K, Yamaue H (2006) Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg 244(1):1–7PubMed Kawai M, Tani M, Terasawa H, Ina S, Hirono S, Nishioka R, Miyazawa M, Uchiyama K, Yamaue H (2006) Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg 244(1):1–7PubMed
44.
Zurück zum Zitat Correa-Gallego C, Brennan MF, D’Angelica M, Fong Y, Dematteo RP, Kingham TP, Jarnagin WR, Allen PJ (2013) Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution. Ann Surg. In press. Correa-Gallego C, Brennan MF, D’Angelica M, Fong Y, Dematteo RP, Kingham TP, Jarnagin WR, Allen PJ (2013) Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution. Ann Surg. In press.
45.
Zurück zum Zitat Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349(22):2117–2127PubMedCrossRef Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349(22):2117–2127PubMedCrossRef
46.
Zurück zum Zitat Kim CG, Jo S, Kim JS (2012) Impact of surgical volume on nationwide hospital mortality after pancreaticoduodenectomy. World J Gastroenterol 18(31):4175–4181PubMedCrossRef Kim CG, Jo S, Kim JS (2012) Impact of surgical volume on nationwide hospital mortality after pancreaticoduodenectomy. World J Gastroenterol 18(31):4175–4181PubMedCrossRef
47.
Zurück zum Zitat Parks RW, Bettschart V, Frame S, Stockton DL, Brewster DH, Garden OJ (2004) Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study. Br J Cancer 91(3):459–465PubMedCrossRef Parks RW, Bettschart V, Frame S, Stockton DL, Brewster DH, Garden OJ (2004) Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study. Br J Cancer 91(3):459–465PubMedCrossRef
48.
Zurück zum Zitat Rotter T, Kinsman L, James E, Machotta A, Gothe H, Willis J, Snow P, Kugler J (2010) Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev 3, CD006632PubMed Rotter T, Kinsman L, James E, Machotta A, Gothe H, Willis J, Snow P, Kugler J (2010) Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev 3, CD006632PubMed
49.
Zurück zum Zitat Muller MK, Dedes KJ, Dindo D, Steiner S, Hahnloser D, Clavien PA (2009) Impact of clinical pathways in surgery. Langenbecks Arch Surg 394(1):31–39PubMedCrossRef Muller MK, Dedes KJ, Dindo D, Steiner S, Hahnloser D, Clavien PA (2009) Impact of clinical pathways in surgery. Langenbecks Arch Surg 394(1):31–39PubMedCrossRef
50.
Zurück zum Zitat Munitiz V, Martinez-de-Haro LF, Ortiz A, Ruiz-de-Angulo D, Pastor P, Parrilla P (2010) Effectiveness of a written clinical pathway for enhanced recovery after transthoracic (Ivor Lewis) oesophagectomy. Br J Surg 97(5):714–718PubMedCrossRef Munitiz V, Martinez-de-Haro LF, Ortiz A, Ruiz-de-Angulo D, Pastor P, Parrilla P (2010) Effectiveness of a written clinical pathway for enhanced recovery after transthoracic (Ivor Lewis) oesophagectomy. Br J Surg 97(5):714–718PubMedCrossRef
Metadaten
Titel
Pancreatoduodenectomy—current status of surgical and perioperative techniques in Germany
verfasst von
Christina Haane
Wolf Arif Mardin
Britta Schmitz
Sameer Dhayat
Richard Hummel
Norbert Senninger
Christina Schleicher
Soeren Torge Mees
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 8/2013
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-013-1130-1

Weitere Artikel der Ausgabe 8/2013

Langenbeck's Archives of Surgery 8/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.